Evaluating Test Strategies for Colorectal Cancer Screening—Age to Begin, Age to Stop, and Timing of Screening Intervals
暂无分享,去创建一个
Amy B. Knudsen | A. Zauber | K. Kuntz | I. Lansdorp-Vogelaar | A. Knudsen | M. Ballegooijen | J. Wilschut
[1] Rongwei Fu,et al. Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.
[2] Amy B. Knudsen,et al. Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.
[3] Jennifer S. Lin,et al. Screening for Colorectal Cancer: An Updated Systematic Review , 2008 .
[4] B. Levin,et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.
[5] Charles Wiggins,et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. , 2007, Cancer.
[6] J. Johanson,et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. , 2006, The New England journal of medicine.
[7] Deborah Schrag,et al. How much can current interventions reduce colorectal cancer mortality in the U.S.? , 2006, Cancer.
[8] Robert H Fletcher,et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. , 2006, CA: a cancer journal for clinicians.
[9] Robert H Fletcher,et al. Guidelines for Colonoscopy Surveillance after Polypectomy: A Consensus Update by the US Multi‐Society Task Force on Colorectal Cancer and the American Cancer Society * , † , 2006, Gastroenterology.
[10] P. Bossuyt,et al. Polyp Miss Rate Determined by Tandem Colonoscopy: A Systematic Review , 2006, The American Journal of Gastroenterology.
[11] L. Seeff,et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? , 2004, Gastroenterology.
[12] David F Ransohoff,et al. Are Physicians Doing Too Much Colonoscopy? A National Survey of Colorectal Surveillance after Polypectomy , 2004, Annals of Internal Medicine.
[13] A. Zauber,et al. A Comparison of the Cost-Effectiveness of Fecal Occult Blood Tests with Different Test Characteristics in the Context of Annual Screening in the Medicare Population , 2003 .
[14] C. Klabunde,et al. Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. , 2003, The American journal of medicine.
[15] S. Woolf,et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. , 2003, Gastroenterology.
[16] Ahmedin Jemal,et al. Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden , 2002, Cancer.
[17] D. Mark. Visualizing cost-effectiveness analysis. , 2002, JAMA.
[18] L M Schuman,et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. , 2000, The New England journal of medicine.
[19] Graham A. Colditz,et al. Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.
[20] J D Habbema,et al. Endoscopic colorectal cancer screening: a cost-saving analysis. , 2000, Journal of the National Cancer Institute.
[21] T. Church,et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. , 1999, Journal of the National Cancer Institute.
[22] Rob Boer,et al. The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening , 1999, Comput. Biomed. Res..
[23] J. Olsen,et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.
[24] L M Schuman,et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.
[25] P. J. Young,et al. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. , 1992, Gut.
[26] N. O. Jacobsen,et al. Polyps of the large intestine in Aarhus, Denmark. An autopsy study. , 1989, Scandinavian journal of gastroenterology.
[27] S. Moss,et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.
[28] Yrjö Collan,et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large‐bowel cancer , 1985, International journal of cancer.
[29] D W Day,et al. Polyps and cancer of the large bowel: a necropsy study in Liverpool. , 1982, Gut.
[30] M. Vatn,et al. The prevalence of polyps of the large intestine in Oslo: An autopsy study , 1982, Cancer.
[31] E. C. Hammond,et al. Adenomatous lesions of the large bowel: An autopsy survey , 1979, Cancer.
[32] T C ARMINSKI,et al. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations , 1964, Diseases of the colon and rectum.
[33] I CHAPMAN,et al. Adenomatous Polypi of Large Intestine: Incidence and Distribution , 1963, Annals of surgery.
[34] Amy B. Knudsen,et al. Cost-Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer , 2007 .
[35] T. Morikawa,et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. , 2005, Gastroenterology.
[36] Screening for colorectal cancer: recommendation and rationale. , 2002, American family physician.
[37] J. R. Scotti,et al. Available From , 1973 .
[38] F. V. von Eyben,et al. Colorectal cancer screening: clinical guidelines and rationale. , 1997, Gastroenterology.
[39] D. Calvillo Ayala. Polyps of the colon and rectum. , 1971, The American journal of gastroenterology.
[40] J W BAKER,et al. Polyps of the colon. , 1962, Surgery, gynecology & obstetrics.